Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04865939 · ClinicalTrials.gov registry record · Phase 3
Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma
A Phase 3 study of Urothelial Cancer of Renal Pelvis and Urothelial Carcinoma Ureter, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT04865939 is a Phase 3 study of Urothelial Cancer of Renal Pelvis and Urothelial Carcinoma Ureter that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 132 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04865939, a Phase 3 study of Urothelial Cancer of Renal Pelvis and Urothelial Carcinoma Ureter, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
There is a high rate of intravesical (bladder) recurrence following extirpative surgery for upper tract urothelial carcinoma. There is no single established standard of care for prevention of intravesical recurrence; however, one protocol in common use involves the use of intravesical gemcitabine instilled into the bladder during surgery and prior to entry into the bladder. There are barriers to the use of gemcitabine, especially at lower volume centers. Some evidence suggests that intravesical irrigation with sterile water has equivalent efficacy to intravesical chemotherapy in prevention of recurrent bladder cancer following transurethral resection of bladder tumors (TURBT). This study is intended to compare recurrence rates using intravesical gemcitabine (as a pseudo-standard of care) and continuous bladder irrigation with sterile water.
Conditions Studied
Interventions
- DRUG Gemcitabine
- PROCEDURE sterile water irrigation
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2021-11-29 |
| Est. Completion | 2031-11-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04865939
The ClinicalTrials.gov registry entry for NCT04865939 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Urothelial Cancer of Renal Pelvis appearing as the primary indexed condition, and to 2 interventions - of which Gemcitabine is the first listed.
NCT04865939 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04865939 about?
NCT04865939 is a clinical study titled "Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma". There is a high rate of intravesical (bladder) recurrence following extirpative surgery for upper tract urothelial carcinoma. There is no single established standard of care for prevention of intravesical recurrence; however, one protocol in common use involves the use of intravesical gemcitabine in...
What is the current status of trial NCT04865939?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 132 participants. The study started on 2021-11-29. Estimated completion is 2031-11-01.
What conditions does trial NCT04865939 study?
This clinical trial studies the following conditions: Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma Ureter.
What interventions are being tested in trial NCT04865939?
The interventions under investigation include: Gemcitabine (DRUG), sterile water irrigation (PROCEDURE).
Who is sponsoring clinical trial NCT04865939?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04865939 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urothelial Cancer of Renal Pelvis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.